Genetic testing in patients with epilepsy can yield useful information that informs treatment and improves seizure control and other outcomes,
Genetic Testing Valuable in the Clinical Management of Epilepsy
Home ยป
Study uncovers mutations in Polycomb group gene as underlying cause of novel neurological disorder
A multi-institutional study has discovered spontaneous mutations in RNF2 (RING2) gene as the underlying cause of a novel neurological disorder.
Wireless neuromodulation technology could improve the lives of patients with brain disorders
Scientists make pivotal discovery of method for wireless modulation of neurons with X-rays that could improve the lives of patients
Low-frequency brain stimulation prevents seizures in mice with temporal lobe epilepsy
Epileptic activity originating from one or more diseased brain regions in the temporal lobe is difficult to contain. Many patients
Screen size matters: Consumers less attentive to news content on small screens
If you’re getting your news from a smartphone, size matters. Heart rate variability decreases and changes in sweat are muted
FDA Approves First Generic Version of Epilepsy Drug Sabril
THURSDAY, Jan. 17, 2019 — The first generic version of Sabril (vigabatrin) has been approved by the U.S. Food and
Criticism from parents affects how children’s brains respond to emotional information: Children with critical parents pay less attention to emotional facial expressions, new research shows
Children of highly critical parents show less attention to emotional facial expressions, according to new research from Binghamton University, State
Why marijuana fans should not see approval for epilepsy drug as a win for weed
A Food and Drug Administration panel recommended approval of a drug made of cannabidiol on April 19 to treat two